OncoGenex Pharmaceuticals (United States)

Recent papers from OncoGenex Pharmaceuticals (United States)

1. Generating drug resistance models in human and murine cancer cell lines and assessing cross-resistance to chemotherapeutics and KRAS inhibitorsSTAR Protocols · 2026
2. D102-18 Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-adjusted Indirect Comparison (MAIC)American Journal of Respiratory and Critical Care Medicine · 2026
3. Developing a therapeutic elastase that stimulates anti-tumor immunity by selectively killing cancer cellsCell Reports Medicine · 2025
4. Characterisation of the Oral Microbiome in Women With Fibromyalgia: An Observational Case–Control StudyEuropean Journal of Pain · 2025
5. CRISPR/Cas9 screen identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer2023
6. Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled TrialBioDrugs · 2023
7. A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialThe Oncologist · 2019
8. National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast CancerJournal of Clinical Oncology · 2018
9. Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration‐resistant prostate cancer treated with custirsenCancer Medicine · 2013
10. Identification of Id2 as a Globin Regulatory Protein by Representational Difference Analysis of K562 Cells Induced To Express γ-Globin with a Fungal CompoundMolecular and Cellular Biology · 1999
11. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonucleaseJournal of Cell Science · 1993
12. Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibody.1992
13. Identification of an enhancer involved in the melanoma-specific expression of the tumor antigen melanotransferrin geneNucleic Acids Research · 1992
14. Humoral Immune Responses to Porphyromonas gingivalis Before and Following Therapy in Rapidly Progressive Periodontitis PatientsJournal of Periodontology · 1991
15. Enhanced sulfated‐proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant transforming growth factor‐β₁Journal of Cellular Physiology · 1991
16. Radioimmunotherapy for Breast Cancer: Treatment of a Patient with I-131 L6 Chimeric Monoclonal AntibodyThe International Journal of Biological Markers · 1991
17. Production of transforming growth factor beta 1 during repair of arterial injury.Journal of Clinical Investigation · 1991
18. Evidence for involvement of glycoprotein-CD45 phosphatase in reversing glycoprotein-CD3-induced microtubule-associated protein-2 kinase activity in Jurkat T-cellsBiochemical Journal · 1991
19. Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface.The Journal of Cell Biology · 1991
20. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemiaAmerican Journal of Hematology · 1991